Copyright
©The Author(s) 2017.
World J Gastroenterol. Mar 7, 2017; 23(9): 1552-1567
Published online Mar 7, 2017. doi: 10.3748/wjg.v23.i9.1552
Published online Mar 7, 2017. doi: 10.3748/wjg.v23.i9.1552
Table 2 Sensitivity and specificity of nucleic acid amplification test assays for the detection of Clostridium difficile
Assay | Sensitivity | Specificity | Ref. |
Cepheid Xpert C. difficile | 90%-100% | 92.9%-98.6% | [87,89,91] |
IMDx C. difficile for Abbott m2000 Assay | 62.1%-92.8% | 99.4%-100% | [92,93] |
BD Max Cdiff Assay | 81.6%-96.9% | 95%-95.8% | [92,93] |
Portrait Toxigenic C. difficile Assay | 98.2% | 92.8% | [95] |
Quidel Lyra Direct C. difficile Assay | 82.1%-85.7% | 96.9%-98.3% | [96] |
Verigene C. difficile nucleic acid test | 95.2%-98.7% | 87.5%-99.4% | [97,128] |
Simplexa C. difficile Universal Direct real time PCR | 87%-98% | 100% | [99,128] |
AmpliVue C. difficile assay | 91%-96% | 89%-100% | [99,100] |
Illumigene C. difficile assay | 93.3%-100% | 95.1%-100% | [95,101] |
BD GeneOhm Cdiff assay | 89.6%-97.4% | 96.7%-98.5% | [95,103] |
ProGastro Cd assay | 77.93%-100% | 93.4%-99.2% | [103,104] |
- Citation: Martínez-Meléndez A, Camacho-Ortiz A, Morfin-Otero R, Maldonado-Garza HJ, Villarreal-Treviño L, Garza-González E. Current knowledge on the laboratory diagnosis of Clostridium difficile infection. World J Gastroenterol 2017; 23(9): 1552-1567
- URL: https://www.wjgnet.com/1007-9327/full/v23/i9/1552.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i9.1552